Ostermann, M., Corteville, D. C., Doi, K., Koyner, J. L., Lamy, A., Li, G., . . . Engelman, D. T. A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS). BMC.
Chicago Style (17th ed.) CitationOstermann, Marlies, et al. A Phase 3 Study of Ravulizumab to Protect Patients with Chronic Kidney Disease from Cardiac Surgery-associated Acute Kidney Injury and Major Adverse Kidney Events (ARTEMIS). BMC.
MLA (9th ed.) CitationOstermann, Marlies, et al. A Phase 3 Study of Ravulizumab to Protect Patients with Chronic Kidney Disease from Cardiac Surgery-associated Acute Kidney Injury and Major Adverse Kidney Events (ARTEMIS). BMC.
Warning: These citations may not always be 100% accurate.